Gastrointestinal Tumor Study Group, “Prolongation of the Disease-Free Interval in Surgically Treated Rectal Carcinoma,” The New England Journal of Medicine, Vol. 312, No. 23, 1985, pp. 1465-1472. doi:10.1056/NEJM198506063122301
 Medical Research Council Rectal Cancer Working Party, “Randomised Trial of Surgery Alone versus Radiotherapy Followed by Surgery for Potentially Operable Locally Advanced Rectal Cancer,” Lancet, Vol. 348, No. 9042, 1996, pp. 1605-1610. doi:10.1016/S0140-6736(96)05348-2
 S. F. Sells, D. P. Wood Jr., S. S. Joshi-Barve, S. Muthukumar, R. J. Jacob, S. A. Crist, et al., “Commonality of the Gene Programs Induced by Effectors of Apoptosis in Androgen-Dependent and -Independent Prostate Cells,” Cell Growth & Differentiation, Vol. 5, No. 4, 1994, pp. 457-466.
 R. Burikhanov, Y. Zhao, A. Goswami, S. Qiu, S. R. Schwarze and V. M. Rangnekar, “The Tumor Suppressor Par-4 Activates an Extrinsic Pathway for Apoptosis,” Cell, Vol. 138, No. 2, 2009, pp. 377-388. doi:10.1016/j.cell.2009.05.022
 C. L. Kline, S. S. Shanmugavelandy, M. Kester and R. B. Irby, “Delivery of Par-4 Plasmid in Vivo Via Nanoliposomes Sensitizes Colon Tumor Cells Subcutaneously Implanted into Nude Mice to 5-Fu,” Cancer Biology & Therapy, Vol. 8, No. 19, 2009, pp. 1831-1837. doi:10.4161/cbt.8.19.9592
 S. Boehrer, D. Nowak, E. Puccetti, M. Ruthardt, N. Sattler, B. Trepohl, et al., “Prostate-Apoptosis-Response-Gene-4 Increases Sensitivity to Trail-Induced Apoptosis,” Leukemia Research, Vol. 30, No. 5, 2006, pp. 597-605.
 J. Cook, S. Krishnan, S. Ananth, S. F. Sells, Y. Shi, M. M. Walther, et al., “Decreased Expression of the Pro-Apoptotic Protein Par-4 in Renal Cell Carcinoma,” Oncogene, Vol. 18, No. 5, 1999, pp. 1205-1208. doi:10.1038/sj.onc.1202416
 S. F. Sells, S. S. Han, S. Muthukkumar, N. Maddiwar, R. Johnstone, E. Boghaert, et al., “Expression and Function of the Leucine Zipper Protein Par-4 in Apoptosis,” Molecular and Cellular Biology, Vol. 17, No. 7, 1997, pp. 3823-3832.
 M. M. Shareef, N. Cui, R. Burikhanov, S. Gupta, S. Satishkumar, S. Shajahan, et al., “Role of Tumor Necrosis Factor-Alpha and Trail in High-Dose Radiation-Induced Bystander Signaling in Lung Adenocarcinoma,” Cancer Research, Vol. 67, No. 24, 2007, pp. 11811-11820.
 M. Barradas, A. Monjas, M. T. Diaz-Meco, M. Serrano and J. Moscat, “The Downregulation of the Pro-Apoptotic Protein Par-4 Is Critical for Ras-Induced Survival and Tumor Progression,” The EMBO Journal, Vol. 18, No. 1999, pp. 6362-6369.
 G. Moreno-Bueno, P. J. Fernandez-Marcos, M. Collado, M. J. Tendero, S. M. Rodriguez-Pinilla, I. Garcia-Cao, et al., “Inactivation of the Candidate Tumor Suppressor Par-4 in Endometrial Cancer,” Cancer Research, Vol. 67, No. 5, 2007, pp. 1927-1934. doi:10.1158/0008-5472.CAN-06-2687
 M. M. Ahmed, D. Sheldon, M. A. Fruitwala, K. Venkatasubbarao, E. Y. Lee, S. Gupta, et al., “Downregulation of Par-4, a Pro-Apoptotic Gene, in Pancreatic Tumors Harboring K-Ras Mutation,” International Journal of Cancer, Vol. 122, No. 1, 2008, pp. 63-70. doi:10.1002/ijc.23019
 S. Vetterkind, M. Boosen, K. H. Scheidtmann and U. Preuss, “Ectopic Expression of Par-4 Leads to Induction of Apoptosis in Cns Tumor Cell Lines,” International Journal of Oncology, Vol. 26, No. 1, 2005, pp. 159-167.
 A. K. Sharma, C. L. Kline, A. Berg, S. Amin and R. B. Irby, “The Akt Inhibitor Isc-4 Activates Prostate Apoptosis Response Protein-4 and Reduces Colon Tumor Growth in a Nude Mouse Model,” Clinical Cancer Research, Vol. 17, No. 13, 2011, pp. 4474-4483.